Clominorex

Clominorex
Clinical data
ATC code	none;
Identifiers
	IUPAC name (RS)-5-(4-chlorophenyl)-4,5-dihydro-1,3-oxazol-2-amine;
CAS Number	3876-10-6 ;
PubChem CID	19752;
ChemSpider	18605 ;
UNII	O1R2462WA0;
KEGG	D03552 ;
ChEMBL	ChEMBL2104179;
CompTox Dashboard (EPA)	DTXSID30863286 ;
Chemical and physical data
Formula	C9H9ClN2O
Molar mass	196.63 g·mol−1
3D model (JSmol)	Interactive image;
Chirality	Racemic mixture
	SMILES Clc1ccc(cc1)C2O\C(=N/C2)N;
	InChI InChI=1S/C9H9ClN2O/c10-7-3-1-6(2-4-7)8-5-12-9(11)13-8/h1-4,8H,5H2,(H2,11,12) ; Key:HAHOPPGVHWVBRR-UHFFFAOYSA-N ;
	(verify)

Clominorex is a centrally acting sympathomimetic which is related to other drugs such as aminorex and pemoline. It was developed as an appetite suppressant by McNeil Laboratories in the 1950s.^[1]

References

^ Maier J, Mayer FP, Brandt SD, Sitte HH (October 2018). "DARK Classics in Chemical Neuroscience: Aminorex Analogues". ACS Chemical Neuroscience. 9 (10): 2484–2502. doi:10.1021/acschemneuro.8b00415. PMC 6287711. PMID 30269490.

This drug article relating to the nervous system is a stub. You can help Wikipedia by expanding it.